MedTrace Logo

Regulatory Hycamtin(Oral) PMS

NCT01037023 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 92

Last updated 2015-04-15

No results posted yet for this study

Summary

Non-interventional, open-label, single group, multicentric post-marketing surveillance to monitor the safety and effectiveness of Topotecan administered in Korean patients according to the prescribing information

Conditions

  • Lung Cancer, Small Cell

Interventions

DRUG

Topotecan

patients administrated Topotecan according to the prescribing information

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2014-11-30
Completion
2014-11-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01037023 on ClinicalTrials.gov